19-41397794-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000540732.3(ENSG00000255730):​c.211-12843T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.133 in 1,605,510 control chromosomes in the GnomAD database, including 15,174 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 907 hom., cov: 33)
Exomes 𝑓: 0.14 ( 14267 hom. )

Consequence

ENSG00000255730
ENST00000540732.3 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.433

Publications

25 publications found
Variant links:
Genes affected
BCKDHA (HGNC:986): (branched chain keto acid dehydrogenase E1 subunit alpha) The branched-chain alpha-keto acid (BCAA) dehydrogenase (BCKD) complex is an innter mitochondrial enzyme complex that catalyzes the second major step in the catabolism of the branched-chain amino acids leucine, isoleucine, and valine. The BCKD complex consists of three catalytic components: a heterotetrameric (alpha2-beta2) branched-chain alpha-keto acid decarboxylase (E1), a dihydrolipoyl transacylase (E2), and a dihydrolipoamide dehydrogenase (E3). This gene encodes the alpha subunit of the decarboxylase (E1) component. Mutations in this gene result in maple syrup urine disease, type IA. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
BCKDHA Gene-Disease associations (from GenCC):
  • maple syrup urine disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • maple syrup urine disease type 1A
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P, Myriad Women’s Health, ClinGen
  • classic maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermittent maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • thiamine-responsive maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 19-41397794-T-G is Benign according to our data. Variant chr19-41397794-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93334.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.148 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BCKDHANM_000709.4 linkc.-34T>G upstream_gene_variant ENST00000269980.7 NP_000700.1 P12694-1A0A024R0K3
BCKDHANM_001164783.2 linkc.-34T>G upstream_gene_variant NP_001158255.1 P12694Q59EI3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000255730ENST00000540732.3 linkc.211-12843T>G intron_variant Intron 2 of 9 2 ENSP00000443246.1 F5H5P2
BCKDHAENST00000269980.7 linkc.-34T>G upstream_gene_variant 1 NM_000709.4 ENSP00000269980.2 P12694-1

Frequencies

GnomAD3 genomes
AF:
0.102
AC:
15471
AN:
152214
Hom.:
908
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0382
Gnomad AMI
AF:
0.156
Gnomad AMR
AF:
0.106
Gnomad ASJ
AF:
0.142
Gnomad EAS
AF:
0.0468
Gnomad SAS
AF:
0.157
Gnomad FIN
AF:
0.0937
Gnomad MID
AF:
0.127
Gnomad NFE
AF:
0.138
Gnomad OTH
AF:
0.100
GnomAD2 exomes
AF:
0.115
AC:
28721
AN:
249866
AF XY:
0.121
show subpopulations
Gnomad AFR exome
AF:
0.0366
Gnomad AMR exome
AF:
0.0674
Gnomad ASJ exome
AF:
0.136
Gnomad EAS exome
AF:
0.0528
Gnomad FIN exome
AF:
0.0966
Gnomad NFE exome
AF:
0.139
Gnomad OTH exome
AF:
0.124
GnomAD4 exome
AF:
0.136
AC:
197327
AN:
1453178
Hom.:
14267
Cov.:
30
AF XY:
0.137
AC XY:
99142
AN XY:
723392
show subpopulations
African (AFR)
AF:
0.0365
AC:
1215
AN:
33300
American (AMR)
AF:
0.0713
AC:
3184
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.133
AC:
3473
AN:
26076
East Asian (EAS)
AF:
0.0498
AC:
1976
AN:
39652
South Asian (SAS)
AF:
0.158
AC:
13583
AN:
86032
European-Finnish (FIN)
AF:
0.0973
AC:
5193
AN:
53390
Middle Eastern (MID)
AF:
0.163
AC:
902
AN:
5528
European-Non Finnish (NFE)
AF:
0.145
AC:
159816
AN:
1104462
Other (OTH)
AF:
0.133
AC:
7985
AN:
60060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
8969
17938
26908
35877
44846
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5722
11444
17166
22888
28610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.102
AC:
15470
AN:
152332
Hom.:
907
Cov.:
33
AF XY:
0.100
AC XY:
7455
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.0382
AC:
1590
AN:
41588
American (AMR)
AF:
0.106
AC:
1621
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.142
AC:
493
AN:
3472
East Asian (EAS)
AF:
0.0463
AC:
240
AN:
5178
South Asian (SAS)
AF:
0.157
AC:
760
AN:
4832
European-Finnish (FIN)
AF:
0.0937
AC:
995
AN:
10622
Middle Eastern (MID)
AF:
0.122
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
0.138
AC:
9380
AN:
68020
Other (OTH)
AF:
0.101
AC:
213
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
718
1436
2154
2872
3590
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.121
Hom.:
1412
Bravo
AF:
0.0983
Asia WGS
AF:
0.100
AC:
346
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Maple syrup urine disease Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

BCKDHA-related disorder Benign:1
Jul 21, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.93
DANN
Benign
0.50
PhyloP100
-0.43
PromoterAI
-0.13
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45500792; hg19: chr19-41903699; API